Skip to main content
. Author manuscript; available in PMC: 2021 Jun 16.
Published in final edited form as: Mod Pathol. 2020 Dec 16;34(5):994–1007. doi: 10.1038/s41379-020-00721-6

Table 1.

Clinicopathologic characteristics of synchronous endometrial and ovarian cancer cases arising in patients with DNA mismatch repair-deficiency associated syndromes

Case ID Age at diagnosis (years) Germline mutation Site Bilateral ovarian disease Histology Tumor grade FIGO Stage Myometrial invasion Cervical invasion LVI Endometriosis Clinical diagnosis Somatic MMR LOH MSIsensor score Status Follow up (years)
LS2- CMMRD 39 PMS2 p.S8fs* homozygous Uterus Endometrioid G1 IIIC1 <50% Yes Yes Synchronous primaries No 5 DOC 7
Ovary Yes Endometrioid G1 IB No 8
LS3 41 MSH2 p.Q324fs* heterozygous Uterus Endometrioid; clear cell features G2 IB >50% No Yes Synchronous primaries No 55 NED 13
Ovary No Clear cell IA No 32
LS4 49 PMS2 p.Q30* heterozygous Uterus Endometrioid G1 IA None No No Synchronous primaries Yes 35 AWD 9
Ovary No Endometrioid G2 IC Yes 31
LS5 49 MSH2 p.Y521* heterozygous Uterus Endometrioid G1 II Superficial Yes No Synchronous primaries No 15 NED 2
Ovary No Endometrioid G1 IA Yes 26
LS6 56 MSH6 p.R1334P heterozygous Uterus Endometrioid G1 IA None No No Synchronous primaries No ND NED 1
Ovary No Endometrioid G1 IA No ND

AWD, alive with disease. CMMRD, constitutional mismatch repair deficiency; DOC, dead of other cause; LOH, loss of heterozygosity; LS, Lynch syndrome; LVI, lymphovascular space invasion; MMR, mismatch repair; NED, no evidence of disease; ND, not defined.